4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-057703
Director sold 4,600 shares at $17.94 ($82,524)
- Director acquired 10,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
CHESS ROBERT · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-22 | Grant or award : show line 1 in the form | +10,200 | 284,473 | D | ||
| 2021-09-22 | Sale : show line 2 in the form | −4,600 | $17.94 | $82,524 | 279,873 | D |
| Open-market sales · 4,600 sh · avg $17.94 · $82,524 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-22 | Grant or award : show line 3 in the form Stock Option | +20,400 | 20,400 | D |
Loading xslF345X03/doc4.xml…